BioGaia
109,5
SEK
-0,36 %
BIOG B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
3 investorer følger denne virksomhed
-0,36%
+6,1%
-4,95%
-12,54%
+8,2%
+10,16%
+6,73%
+32,73%
+1.441,54%
BioGaia is a biotechnology company. The company develops, markets and sells probiotic products. The products are mainly based on the bacterium Lactobacillus, which has probiotic effects. Today, the company's products are sold around the global market. Research and development are conducted via the company's external network of research institutions and clinics. The head office is located in Stockholm.
Læs mereMarkedsværdi
11,08 mia. SEK
Aktieomsætning
13,13 mio. SEK
Omsætning
1,3 mia.
EBIT %
34,18 %
P/E
30,25
Udbytteafkast, %
6,3 %
Finanskalender
12.2
2025
Årsrapport '24
7.5
2025
Generalforsamling '24
7.5
2025
Delårsrapport Q1'25
ViserAlle indholdstyper
BioGaia, Audiocast with teleconference, Q3'24
BioGaia AB: Interim Management Statement January - September 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools